Seer (SEER) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Seer (SEER) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
67.94% |
| 10 |
Seer |
95.75 Mn |
95.75 Mn |
982,000.00 |
-827.86% |
| Date | Value |
|---|
| Mar 31, 2026 |
-827.86% |
| Dec 31, 2025 |
55.71% |
| Sep 30, 2025 |
15.17% |
| Mar 31, 2025 |
92.07% |
| Dec 31, 2024 |
-496.69% |
| Sep 30, 2024 |
95.80% |
| Jun 30, 2024 |
74.07% |
| Mar 31, 2024 |
-190.46% |
| Dec 31, 2023 |
164.34% |
| Sep 30, 2023 |
-1,951.85% |
| Jun 30, 2023 |
-35.93% |
| Mar 31, 2023 |
98.00% |
| Dec 31, 2022 |
62.17% |
| Dec 31, 2021 |
-162.34% |
